Notice of Intent to Sole Source – Biomerieux

The National Institutes of Health (NIH) intends to award a fixed price purchase order to BioMeriux Inc. to provide reagents and supplies for mycoplasma testing and routine lab work. The reagents and supplies are specific for the existing instrumentation and clinical tests, and are the only ones that can meet the regulatory cGMP standards. The acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures. • The place of performance is Bethesda, MD 20892 USA. • The NAICS Code is 339112 – Surgical and Medical Instrument Manufacturing. • The Product Service Code is 6515 – Medical Instruments, Equipment, and Supplies. • The acquisition is for one year's supply of reagents and supplies.